CRISPR Therapeutics AG (CRSP) Nathan Winklepleck, CFA's Nathan's Discounted Free Cash Flow - Discounting Cash Flows
CRSP
CRISPR Therapeutics AG
CRSP (NASDAQ)

Estimated Value

USD

Market Price USD

* Values are not guaranteed, please do your own
research before making investment decisions.

Nathan's Discounted Free Cash Flow Model

The Discounted Free Cash Flow (DCF) model calculates the value of a company by estimating its future Free Cash Flows to the Firm (FCFF) and discounting them to their present value. The value of a share is then derived by adjusting for net debt and dividing by the number of shares outstanding.

Check out Nathan's YouTube Channel

Interactive Assumptions

Discount Rate

Discount Rate

Discount Rate = 10 Year Treasury Note Yield + 4%

Growth In Perpetuity

Growth in Perpetuity

The rate at which the company's free cash flow is assumed to grow indefinitely. By default, this rate equals the yield of the U.S. 10-Year Treasury Bond.

Historical Years

Historical Years

The number of years of historical data used to calculate averages and trends for analysis.

Projection Years

Projection Years

The number of years into the future for which the analysis projects financial performance and metrics.

Revenue Growth Rate

Revenue Growth Rate

The annual growth rate applied to projected revenue, starting from the second projection year onward.

Operating Cash Flow Margin

Operating Cash Flow Margin

Projected Operating Cash Flow = Projected Revenue * Operating Cash Flow Margin

This margin represents the percentage of revenue used to estimate future Operating Cash Flow.

Capital Expenditure Margin

Capital Expenditure Margin

Projected Free Cash Flow = Projected Operating Cash Flow - Projected Revenue * Capital Expenditure Margin

This margin is used to estimate future capital expenditures as a percentage of revenue, which in turn is subtracted from Operating Cash Flow to calculate Free Cash Flow.

Results

Terminal Value -174,479,995,215,878,225,920 Bil. USD
Discounted Terminal Value -78,897,894,409,186,099,200 Bil. USD
Sum of Discounted Free Cash Flow -6,868,618,785,511,633,920 Bil. USD
Enterprise Value -85,766,513,194,697,719,808 Bil. USD
Cash and Equivalents 286.5 Mil. USD
Total Debt 211 Mil. USD
Equity Value -85,766,513,194,697,719,808 Bil. USD
Shares Outstanding 91.31 Mil. USD
Estimated Value per Share -939,337,348,864 Bil. USD
Yield of the U.S. 10 Year Treasury Note 4.26%
Average Cash from Operating Activities Margin -11,670%
Average Capital Expenditure Margin -1,067%

Monetary values in USD

Edit Chart Values 2025-12-31 2026-12-31 2027-12-31 2028-12-31 2029-12-31 2030-12-31 2031-12-31 2032-12-31 2033-12-31 2034-12-31

Monetary values in USD

amounts except #

2025
Dec 31
2026
Dec 31
2027
Dec 31
2028
Dec 31
2029
Dec 31
2030
Dec 31
2031
Dec 31
2032
Dec 31
2033
Dec 31
2034
Dec 31
Revenue 7,844 1,563,334 272,851,293 40,858,808,083 5,105,854,670,063 511,500,549,626,578 38,564,618,039,132,496 1,951,790,455,612,486,912 50,408,414,992,770,072,576 52,555,813,471,460,302,848
Revenue Growth Rate 22,310% 19,830% 17,350% 14,870% 12,400% 9,918% 7,440% 4,961% 2,483% 4.26%
Operating Cash Flow -915,336 -182,441,057 -31,841,745,885 -4,768,222,903,321 -595,853,239,996,312 -59,692,114,141,421,680 -4,500,490,925,166,763,008 -227,773,946,169,977,241,600 -5,882,662,029,656,267,423,744 -6,133,263,432,119,417,307,136
Operating Cash Flow Margin -11,670% -11,670% -11,670% -11,670% -11,670% -11,670% -11,670% -11,670% -11,670% -11,670%
Capital Expenditure -83,690 -16,680,772 -2,911,323,296 -435,963,482,249 -54,479,469,329,569 -5,457,710,864,515,585 -411,484,474,477,544,064 -20,825,604,161,385,242,624 -537,857,787,972,856,512,512 -560,770,529,740,481,298,432
Capital Expenditure Margin -1,067% -1,067% -1,067% -1,067% -1,067% -1,067% -1,067% -1,067% -1,067% -1,067%
Free Cash Flow -999,027 -199,121,829 -34,753,069,181 -5,204,186,385,569 -650,332,709,325,881 -65,149,825,005,937,264 -4,911,975,399,644,307,456 -248,599,550,331,362,508,800 -6,420,519,817,629,124,263,936 -6,694,033,961,859,898,408,960
Free Cash Flow Margin -12,740% -12,740% -12,740% -12,740% -12,740% -12,740% -12,740% -12,740% -12,740% -12,740%
Compounded Discount Rate 0% 7.53% 16.41% 26.06% 36.47% 47.74% 59.95% 73.2% 87.5% 103%
Discounted Free Cash Flow -999,027 -185,173,260 -29,852,763,506 -4,128,399,931,129 -476,536,855,913,029 -44,096,703,847,764,984 -3,071,008,614,800,016,896 -143,536,626,427,482,292,224 -3,424,242,900,435,690,061,824 -3,297,723,672,634,518,929,408

Monetary values in USD

amounts except #

Average LTM
Jan 31
2024
Dec 31
2023
Dec 31
2022
Dec 31
2021
Dec 31
2020
Dec 31
2019
Dec 31
2018
Dec 31
2017
Dec 31
2016
Dec 31
2015
Dec 31
Revenue 154.1 36.75 35 370 0.436 913.1 0.719 289.6 3.12 41 5.16 0.247
Revenue Growth Rate 22,540% 5.01% -90.54% 84,760% -99.95% 126,890% -99.75% 9,170% -92.38% 693.9% 1,991% 24,790%
Cost of Revenue 118.8 167.4 110.2 130.2 110.2 101.2 269.4 179.4 113.8 69.8 42.24 12.57
Gross Profit 35.33 -130.6 -75.25 239.8 -109.8 811.9 -268.7 110.2 -110.6 -28.8 -37.07 -12.33
Gross Margin -6,569% -355.3% -215% 64.8% -25,190% 88.92% -37,370% 38.06% -3,542% -70.26% -717.9% -4,990%
Operating Income -198.9 -574.4 -466.6 -222.5 -673.2 373.5 -354.4 46.74 -158.9 -64.65 -68.13 -25.73
Operating Margin -20,320% -1,563% -1,333% -60.15% -154,390% 40.91% -49,300% 16.14% -5,088% -157.7% -1,319% -10,420%
Net Income -167.7 -488.3 -366.3 -153.6 -650.2 377.7 -348.9 66.86 -165 -68.36 -23.2 -25.83
Net Margin -19,670% -1,329% -1,046% -41.52% -149,120% 41.36% -48,520% 23.09% -5,281% -166.7% -449.3% -10,460%
Cash from Operating Activities -91.48 -302.5 -142.8 -260.4 -495.7 539 -238.4 56.68 -96.24 -70.1 -55.31 59.43
Cash from Operating Activities Margin -11,670% -823% -407.9% -70.37% -113,700% 59.03% -33,150% 19.57% -3,081% -171% -1,071% 24,060%
Capital Expenditure -15.52 -0.651 -1.9 -9.47 -37.19 -81.7 -18.36 -6.68 -2.77 -7.81 -3.02 -1.15
Free Cash Flow -107 -303.1 -144.7 -269.8 -532.9 457.3 -256.7 49.99 -99.01 -77.91 -58.33 58.27
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program